Piper Sandler lowered the firm’s price target on Colgate-Palmolive (CL) to $107 from $108 on slightly lower forward estimates and an unchanged 29-turns 2025 price-to-earnings multiple. The firm keeps an Overweight rating on the shares following a recent catch-up with Colgate-Palmolive and investor conversations exiting Q1.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $89 from $83 at Barclays
- Colgate-Palmolive raises quarterly dividend to 52c from 50c per share
- Colgate-Palmolive announces new $5B share repurchase plan
- Citi Cheers Samuel Adams Parent Boston Beer Stock (NYSE:SAM) Ahead of Sun Cruiser Launch
- Citi names Keurig Dr Pepper top pick in beverages, personal care